title: Thyrotoxic hypokalemic periodic paralysis as the first manifestation of interferon-alpha-induced Graves disease.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Cesur
authors.forename: Alptekin
authors.initials: A
authors.lastname: Gursoy
authors.forename: Ufuk
authors.initials: U
authors.lastname: Avcioglu
authors.forename: Murat Faik
authors.initials: MF
authors.lastname: Erdogan
authors.forename: Demet
authors.initials: D
authors.lastname: Corapcioglu
authors.forename: Nuri
authors.initials: N
authors.lastname: Kamel
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006111:Graves Disease / Q000097:blood / Q000139:chemically induced* / Q000150:complications* / Q000175:diagnosis; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D020514:Hypokalemic Periodic Paralysis / Q000097:blood / Q000209:etiology*; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha